Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 27, 2018 FORM 8-K
SC 13G/A Feb 14, 2018 AMENDMENT NO. 2 TO SCHEDULE 13G
SC 13G/A Feb 13, 2018 SC 13G/A
SC 13G Jan 22, 2018 JANUARY 22, 2018
8-K Dec 1, 2017 8-K
10-Q Nov 9, 2017 FORM 10-Q
8-K Nov 9, 2017 8-K
SC 13G/A Oct 10, 2017
8-K Oct 10, 2017 8-K
8-K Sep 21, 2017 8-K
4 Sep 21, 2017 PRIMARY DOCUMENT
424B5 Sep 20, 2017 424B5
8-K Sep 19, 2017 8-K
424B5 Sep 18, 2017 424B5
8-K Sep 18, 2017 FORM 8-K
8-K Sep 12, 2017 FORM 8-K
8-K Aug 8, 2017 FORM 8-K
10-Q Aug 7, 2017 FORM 10-Q
4 Jul 5, 2017 PRIMARY DOCUMENT
8-K Jun 15, 2017 FORM 8-K
8-K Jun 14, 2017 FORM 8-K
4 Jun 12, 2017 FORM 4 SUBMISSION
4 Jun 12, 2017 FORM 4 SUBMISSION
4 Jun 12, 2017 FORM 4 SUBMISSION
4 Jun 12, 2017 FORM 4 SUBMISSION
← Newer Page 17 of 26 · 646 filings Older →